Chimeric cytokine receptors or switch receptors, which convert one cytokine signal into another, are actively being explored to hijack immunosuppressive cytokines produced by tumor or tumor-associated cells to provide proliferative signals to CAR T cells (Figure 3C). This evidence concerns the gene IL18R1 and neoplasm.